Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Splicing the narrative: alternative TARDBP splicing and its relation to neurodegeneration in ALS and FTD
Morgan R. Miller, Megan Dykstra, Sami Barmada
Morgan R. Miller, Megan Dykstra, Sami Barmada
View: Text | PDF
Review Series

Splicing the narrative: alternative TARDBP splicing and its relation to neurodegeneration in ALS and FTD

  • Text
  • PDF
Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are progressive neurodegenerative diseases characterized by the nuclear clearance and cytoplasmic aggregation of transactive response DNA/RNA-binding protein of 43 kDa (TDP43). Alternative splicing of TARDBP, the gene encoding TDP43, leads to a surprising diversity of RNA and protein isoforms with unique functions and potential implications for disease pathogenesis. Here, we review the production, properties, and functional consequences of alternative splicing in the development of ALS and FTD, focusing primarily on TDP43 due to its integral connection with the pathogenesis of sporadic as well as familial forms of these diseases. We synthesize current evidence on the biology of alternative TARDBP splicing, highlight key questions regarding its role in TDP43 proteinopathies such as ALS and FTD, and touch on the larger phenomenon of alternative splicing and its relationship to disease.

Authors

Morgan R. Miller, Megan Dykstra, Sami Barmada

×

Figure 1

TARDBP splicing gives rise to several distinct isoforms.

Options: View larger image (or click on image) Download as PowerPoint

TARDBP splicing gives rise to several distinct isoforms.
(A) Diagram of...
(A) Diagram of the TARDBP locus, with emphasis on exon 2 and the high splicing density region (HSDR) encompassing exon 6, exon 7, and the proximal 3′ untranslated region (3′UTR). Canonical start (ATG) and stop (TAG) codons are illustrated in exons 2 and 6, respectively. Distinct splice donor (d0, d1, d2) and acceptor (a1, a2) sites are labeled in the HSDR, as well as polyadenylation (pA) signals, introns 6–8 (I6–I8), and the deletion of nt 96–106 (del96_106) in exon 2. (B) Table depicting spliced RNA isoforms and corresponding protein variants for each of the splicing events in A. Unique residues encoded by exon 7 are shown in purple (EALH), magenta (KVVL), and red (RPRL), distinguished in each case by the C-terminal 4 aa. NLS, nuclear localization signal; RRM, RNA recognition motif; NTD, N-terminal domain; LCD, low-complexity domain.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts